Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ivermectin for Chikungunya Viral Infection
NCT06259383Phase 3Completed
- Sponsor
- Prince of Songkla University
- Start
- Jan 2018
- Primary completion
- Dec 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of CHILD-IVITAB in chikungunya virus infection, sponsored by Prince of Songkla University. Started Jan 2018; status: completed.
02
Drugs
CHILD-IVITAB
03
Conditions
chikungunya virus infection
Beyond the preview
Go deeper on NCT06259383.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06259383.